Ranitidine-Darnitsa
Drugs for the treatment of peptic ulcers and gastroesophageal reflux disease. Н2 histamine receptor an
Ranitidine is an anti-ulcer drug, an Н2 histamine receptor antagonist. The mechanism of action is due to the competitive inhibition of Н2 histamine receptors on the parietal cell membranes in the gastric mucosa.
– Gastric and duodenal ulcers not associated with Helicobacter pylori (in the exacerbation phase), including ulcers associated with taking nonsteroidal anti-inflammatory drugs (NSAIDs);
– functional dyspepsia;
– chronic gastritis with increased gastric acid secretion in the exacerbation phase;
– gastroesophageal reflux disease (to relieve symptoms) or reflux esophagitis.
Prescribe to adults and children aged over 12 years. To be taken orally without chewing, with a small amount of water, regardless of food intake.